ClinicalTrials.Veeva

Menu

Efficacy of Functional Magnetic Stimulation in Urinary Incontinence (FMS)

V

vghtpe user

Status and phase

Unknown
Phase 2

Conditions

Incontinence

Treatments

Device: FMS (Magstim rapid2)

Study type

Interventional

Funder types

Other

Identifiers

NCT02091947
201010015OB

Details and patient eligibility

About

Functional Magnetic Stimulation (FMS) appears to modulate autonomic and somatic nervous systems that innervate the lower urinary tract. Stimulation of the pudendal afferent nerve near the third sacral root induces relaxation of the detrusor muscles and reinforcement of urethral sphincter. Some preliminary studies had indicated the positive effect of FMS on stress urinary incontinence. Investigators aimed to evaluate the immediate and long-term effect of this method on stress urinary incontinent patients.

Full description

5 Hz repetitive magnetic stimulation was applied over bilateral sacral roots for 20 minutes.

Enrollment

40 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Urine incontinence refractory to traditional treatment

Exclusion criteria

  • Arrhythmia, pacemaker implantation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

experimental group
Experimental group
Description:
Real FMS, 5 Hz, 20 minutes per day, for 10 weekdays.
Treatment:
Device: FMS (Magstim rapid2)
sham group
Sham Comparator group
Description:
sham FMS, 5 Hz, 20 min per day, for 10 weekdays.
Treatment:
Device: FMS (Magstim rapid2)

Trial contacts and locations

1

Loading...

Central trial contact

Po-Yi Tsai, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems